|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Screening
|
|
|
|
Active
|
|
|
|
25 to 70
|
|
|
|
Other
|
|
|
|
DBCG07MRBRCA DBCG07MRBRCA, NCT00413491
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Educational/Counseling/Training, Screening, Treatment
|
|
|
|
Active
|
|
|
|
65 and over
|
|
|
|
Other
|
|
|
|
IRB00000063 NCT00379743
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Screening
|
|
|
|
Active
|
|
|
|
20 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
FT3.6k-2006 NCT00419679
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Screening
|
|
|
|
Active
|
|
|
|
20 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
FER2k NCT00419900
|
|
|
|
|
|
|
|
Last Modified: 5/29/2008  First Published: 3/6/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Educational/Counseling/Training, Screening
|
|
|
|
Active
|
|
|
|
35 to 64
|
|
|
|
NCI
|
|
|
|
TATA-1900215717A1 1900215717A1, NCT00632047
|
|
|
|
|
|
|
|
Last Modified: 6/13/2008  First Published: 9/24/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Biomarker/Laboratory analysis, Diagnostic, Screening
|
|
|
|
Active
|
|
|
|
Adult
|
|
|
|
NCI
|
|
|
|
NCI-02-C-0077 NCT00070460
|
|
|
|
|
|
|
|
Last Modified: 1/24/2008  First Published: 3/24/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
|
|
|
|
Active
|
|
|
|
18 to 64
|
|
|
|
Other
|
|
|
|
RMNHS-2278 EU-20352, NCT00081003
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Screening
|
|
|
|
Active
|
|
|
|
45 to 80
|
|
|
|
Other
|
|
|
|
DAMD17-03-1-0447 NCT00117663
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Health services research, Screening
|
|
|
|
Approved-not yet active
|
|
|
|
20 to 90
|
|
|
|
Other
|
|
|
|
9461700528 NCT00173303
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Educational/Counseling/Training, Health services research, Screening
|
|
|
|
Approved-not yet active
|
|
|
|
21 and over
|
|
|
|
Other
|
|
|
|
RA-2006-025 NCT00379782
|
|
|
|